InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,257.87
(
0.26%
)
Post# of 640607
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

manysevens

Send PM Follow Ignore
Followers 253
Posts 27856
Boards Moderated 8
Alias Born 04/15/2004

manysevens

Re: None

Tuesday, 02/14/2006 8:14:06 AM

Tuesday, February 14, 2006 8:14:06 AM

Post# of 640607
DNAG News

Tuesday , February 14, 2006 07:00 ET

SARASOTA, FL, Feb 14, 2006 (MARKET WIRE via COMTEX) -- DNAPrint Genomics, Inc. (OTC BB: DNAG) today announced that DOCRO, INC (DOCRO) has been retained to provide consulting and product development services to DNAPRINT PHARMACEUTICALS, Inc., its subsidiary drug and diagnostics development company. DOCRO will perform technical and clinical assistance and provide guidance on the regulatory requirements associated with the design of clinical trials necessary to commercialize DNAPrint's recently in-licensed intellectual property relating to glycated CD59.

Maybe not the nuts ... but I think it's enough todrive this thing for a while.

People who say it cannot be done should not interrupt the person doing it.


http://www.perry-mansfield.org/index_fl.html

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up